Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: A case report

European Journal of Neurology

Volumn 16, Issue 4, 2009, Pages

  Kocer, B ^a   Nazliel, B ^a   Oztas, M ^a   Batur, H Z ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Hypothyroidism; Immunopathogenesis; Interferon; Multiple sclerosis; Skin reactions; Vitiligo

Indexed keywords

BETA1A INTERFERON; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; VITILIGO;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-BETA; MULTIPLE SCLEROSIS; SKIN PIGMENTATION; VITILIGO;

EID: 62849096029     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02563.x     Document Type: Letter

References (5)

1. Gold R, Rieckmann P, Chang P, Abdalla J. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study. European Journal of Neurology 2005 12 : 649 656.
2. Seckin D, Durusoy Ç, Şahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatric Dermatology 2004 21 : 577 579.
3. Passeron T, Ortonne JP. Physiopathology and genetics of vitiligo. Journal of Autoimmunity 2005 25 (Suppl. 63 68.
4. Simsek H, Savas C, Akkiz H, Telatar H. Interferon-induced vitiligo in a patient with chronic viral hepatic C infection. Dermatology 1996 193 : 65 66.
5. Schallreuter KU, Lemke R, Brandt O, et al. Vitiligo and other diseases: coexistence or true association? Dermatology 1994 188 : 269 275.